Nabota 200 Units

$90

Nabota 200 UI is a type A botulinum toxin developed by Daewoong Pharmaceutical Co., Ltd. and FDA-approved for safe and effective use. As the first Korean botulinum toxin to enter the U.S. market, Nabota provides a cost-effective alternative to Botox without requiring any changes in handling practices for this potentially hazardous substance.

Developed by Daewoong Pharmaceutical Co., Ltd., a South Korean company with over 30 years of biotechnology expertise, Nabota offers reliable results in reducing wrinkles caused by uncontrolled muscle tone and active facial expressions.

Share
Brand:

    Product Specifications:

    • Main Ingredient: Clostridium Botulinum Toxin A (strain: Clostridium Botulinum CBFC26)
    • Packing Unit: 1 vial containing 200 units

    Key Features:

    • Rapid Action: Noticeable results are visible shortly after the procedure.
    • High Cleanliness Standards: Produced under stringent conditions for maximum safety.
    • Long-Lasting Effects: The results are durable, providing extended smoothness and relaxation.
    • Natural Expressions: Does not cause a “frozen” appearance, ensuring natural facial movements.
    • High Security: Ensures safety for both patients and practitioners through a reliable, FDA-approved formula.
    • Cost-Effective: An affordable option compared to Botox without compromising efficacy.

    Application Areas:

    Nabota 200 UI is ideal for the treatment of:

    • Smoothing Wrinkles: Treats forehead lines, eyebrows, nasolabial folds, crow’s feet, and mouth area.
    • Blepharospasm Elimination (involuntary eye twitching)
    • Hyperhidrosis Treatment (excessive sweating)
    • Botox Lifting (non-surgical lifting of facial features)